TP53 and small cell lung carcinoma: Genomic analyses have shown that the most frequent mutations and chromosomal aberrations in patients with SCLC involve inactivation of the tumor protein 53 (TP53) and/or loss of retinoblastoma 1 (RB1) genes (9, 10).